Affiliation:
1. Department of Medical Science, University of Aveiro, 3810-193 Aveiro, Portugal
2. LAQV-REQUIMTE and Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal
3. CICECO-Aveiro Institute of Materials, University of Aveiro, 3810-193 Aveiro, Portugal
4. iBiMED-Institute of Biomedicine, Department of Medical Science, University of Aveiro, 3810-193 Aveiro, Portugal
Abstract
L-Carnitine, a natural antioxidant found in mammals, plays a crucial role in the transport of long-chain fatty acids across the inner mitochondrial membrane. It is used as a nutritional supplement by professional athletes, improving performance and post-exercise recovery. Additionally, its therapeutic applications, including those in male infertility, have been investigated, as it may act as a defense mechanism against the excessive production of reactive oxygen species (ROS) in the testis, a process that can lead to sperm damage. This effect is achieved by enhancing the expression and activity of enzymes with antioxidant properties. Nevertheless, the mechanisms underlying the benefits of L-Carnitine remain unknown. This review aims to consolidate the current knowledge about the potential benefits of L-Carnitine and its role in male (in)fertility. Considering in vitro studies with Sertoli cells, pre-clinical studies, and investigations involving infertile men, a comprehensive understanding of the effects of L-Carnitine has been established. In vitro studies suggest that L-Carnitine has a direct influence on somatic Sertoli cells, improving the development of germ cells. Overall, evidence supports that L-Carnitine can positively impact male fertility, even at a relatively low dose of 2 g/day. This supplementation enhances sperm parameters, regulates hormone levels, reduces ROS levels, and subsequently improves fertility rates. However, further research is needed to elucidate the underlying mechanisms and establish optimal doses. In conclusion, the role of L-Carnitine in the field of male reproductive health is highlighted, with the potential to improve sperm quality and fertility.
Funder
“Fundação para a Ciência e a Tecnologia”—FCT to IBIMED
LAQV/REQUIMTE
FEDER funds through the COMPETE/QREN, FSE/POPH, and POCI—COMPETE 2020
CICECO-Aveiro Institute of Materials
FCT/MEC
Reference107 articles.
1. World Health Organization (2022, December 09). Infertility. Available online: https://www.who.int/news-room/fact-sheets/detail/infertility.
2. Some of the Factors Involved in Male Infertility: A Prospective Review;Babakhanzadeh;Int. J. Gen. Med.,2020
3. Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: A meta-analysis;Chua;Andrology,2013
4. Male infertility due to testicular disorders;Sharma;J. Clin. Endocrinol. Metab.,2021
5. Gilbert, S.F. (2023, July 07). Spermatogenesis, Developmental Biology, Available online: https://www.ncbi.nlm.nih.gov/books/NBK10095/.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献